{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:03:20Z","timestamp":1789369400741,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":74,"publisher":"Springer US","isbn-type":[{"value":"9781071654958","type":"print"},{"value":"9781071654965","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5496-5_17","type":"book-chapter","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:08:42Z","timestamp":1789366122000},"page":"213-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surface Plasmon Resonance-Based Analysis of Ligand Binding Kinetics in Chikungunya Virus Drug Discovery"],"prefix":"10.1007","author":[{"given":"Ruchi","family":"Rani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushka","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1730-003X","authenticated-orcid":false,"given":"Shailly","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"17_CR1","unstructured":"Chikungunya. Available online: https:\/\/www.who.int\/health-topics\/chikungunya#tab=tab_1"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1371\/JOURNAL.PPAT.0030201","volume":"3","author":"KA Tsetsarkin","year":"2007","unstructured":"Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S (2007) A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3:1895\u20131906. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.0030201","journal-title":"PLoS Pathog"},{"key":"17_CR3","doi-asserted-by":"publisher","unstructured":"Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I et al (2007) Two chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes Albopictus. PLoS One 2:e1168. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0001168","DOI":"10.1371\/JOURNAL.PONE.0001168"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/J.VIROL.2009.07.024","volume":"393","author":"M Solignat","year":"2009","unstructured":"Solignat M, Gay B, Higgs S, Briant L, Devaux C (2009) Replication cycle of chikungunya: a re-emerging arbovirus. Virology 393:183\u2013197.\u2002https:\/\/doi.org\/10.1016\/J.VIROL.2009.07.024","journal-title":"Virology"},{"issue":"1","key":"17_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1146\/annurev-virology-091919-102021","volume":"8","author":"V Kril","year":"2021","unstructured":"Kril V, A\u00efqui-Reboul-Paviet O, Briant L, Amara A (2021) New insights into chikungunya virus infection and pathogenesis. Annu Rev Virol 8(1):327\u2013347","journal-title":"Annu Rev Virol"},{"key":"17_CR6","unstructured":"Chikungunya Vaccines|Chikungunya Virus|CDC. Available online: https:\/\/www.cdc.gov\/chikungunya\/vaccines\/index.html"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0925-4005(98)00321-9","volume":"54","author":"J Homola","year":"1999","unstructured":"Homola J, Yee SS, Gauglitz G (1999) Surface plasmon resonance sensors: review. Sens Actuators B Chem 54:3\u201315. https:\/\/doi.org\/10.1016\/S0925-4005(98)00321-9","journal-title":"Sens Actuators B Chem"},{"key":"17_CR8","unstructured":"Exploring Optimal Interaction Techniques|SPR vs ITC vs MST vs BLI. Available online: https:\/\/nicoyalife.com\/blog\/spr-vs-itc-vs-mst-vs-bli\/"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1111\/FEBS.16397","volume":"289","author":"A Pareek","year":"2022","unstructured":"Pareek A, Kumar R, Mudgal R, Neetu N, Sharma M, Kumar P, Tomar S (2022) Alphavirus antivirals targeting RNA-dependent RNA polymerase domain of NsP4 divulged using surface plasmon resonance. FEBS J 289:4901\u20134924. https:\/\/doi.org\/10.1111\/FEBS.16397","journal-title":"FEBS J"},{"issue":"4","key":"17_CR10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/acsinfecdis.4c00992","volume":"11","author":"S Nehul","year":"2025","unstructured":"Nehul S, Rani R, Walia P, Panda PK, Singh S, Chattopadhyay S, Tomar S (2025) Repurposing efavirenz, the HIV antiretroviral drug for chikungunya virus infection. ACS Infect Dis 11(4):963\u2013976","journal-title":"ACS Infect Dis"},{"key":"17_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/J.JBIOTEC.2025.06.014","volume":"406","author":"CM Moore","year":"2025","unstructured":"Moore CM, Paul MJ, Pinneh E, Shanmugaraj B, Ashall J, Ramalingam S, Hewson R, Diamond MS, Fox JM, Ma JKC (2025) Characterisation of chikungunya virus neutralising monoclonal antibodies expressed in tobacco plants. J Biotechnol 406:53\u201359. https:\/\/doi.org\/10.1016\/J.JBIOTEC.2025.06.014","journal-title":"J Biotechnol"},{"key":"17_CR12","doi-asserted-by":"publisher","unstructured":"Si L, Meng K, Tian Z, Sun J, Li H, Zhang Z, Soloveva V, Li H, Fu G, Xia Q et al (2018) Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes. Sci Adv 4:eaau8408.\u2002https:\/\/doi.org\/10.1126\/SCIADV.AAU8408","DOI":"10.1126\/SCIADV.AAU8408"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"100409","DOI":"10.1016\/J.CRMICR.2025.100409","volume":"9","author":"H Zhang","year":"2025","unstructured":"Zhang H, Shi S, Sun L, Li S, Zhang Y, Li Z, Hou J, Li P, Shen J, Cheng X et al (2025) Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel. Curr Res Microb Sci 9:100409. https:\/\/doi.org\/10.1016\/J.CRMICR.2025.100409","journal-title":"Curr Res Microb Sci"},{"key":"17_CR14","doi-asserted-by":"publisher","unstructured":"Cairns TM, Ditto NT, Atanasiu D, Lou H, Brooks BD, Saw WT, Eisenberg RJ, Cohen GH (2019) Surface plasmon resonance reveals direct binding of herpes simplex virus glycoproteins GH\/GL to GD and locates a GH\/GL binding site on GD. J Virol 93:e00289-19. https:\/\/doi.org\/10.1128\/JVI.00289-19","DOI":"10.1128\/JVI.00289-19"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"112561","DOI":"10.1016\/J.BIOS.2020.112561","volume":"168","author":"H Yoo","year":"2020","unstructured":"Yoo H, Shin J, Sim J, Cho H, Hong S (2020) Reusable surface plasmon resonance biosensor chip for the detection of H1N1 influenza virus. Biosens Bioelectron 168:112561. https:\/\/doi.org\/10.1016\/J.BIOS.2020.112561","journal-title":"Biosens Bioelectron"},{"key":"17_CR16","doi-asserted-by":"publisher","first-page":"10579","DOI":"10.1128\/JVI.00941-06","volume":"80","author":"H Barth","year":"2006","unstructured":"Barth H, Schnober EK, Zhang F, Linhardt RJ, Depla E, Boson B, Cosset F-L, Patel AH, Blum HE, Baumert TF (2006) Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol 80:10579\u201310590. https:\/\/doi.org\/10.1128\/JVI.00941-06","journal-title":"J Virol"},{"key":"17_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/BIOS11080251","volume":"11","author":"P Genova-Kalou","year":"2021","unstructured":"Genova-Kalou P, Dyankov G, Marinov R, Mankov V, Belina E, Kisov H, Strijkova-Kenderova V, Kantardjiev T (2021) SPR-based kinetic analysis of the early stages of infection in cells infected with human coronavirus and treated with hydroxychloroquine. Biosensors (Basel) 11:251. https:\/\/doi.org\/10.3390\/BIOS11080251","journal-title":"Biosensors (Basel)"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/S41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang R, Kim AS, Fox JM, Nair S, Basore K, Klimstra WB, Rimkunas R, Fong RH, Lin H, Poddar S et al (2018) Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557:570\u2013574.\u2002https:\/\/doi.org\/10.1038\/S41586-018-0121-3","journal-title":"Nature"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1074\/JBC.RA119.012303","volume":"295","author":"S Torii","year":"2020","unstructured":"Torii S, Orba Y, Sasaki M, Tabata K, Wada Y, Carr M, Hobson-Peters J, Hall RA, Takada A, Fukuhara T et al (2020) Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle. J Biol Chem 295:7941. https:\/\/doi.org\/10.1074\/JBC.RA119.012303","journal-title":"J Biol Chem"},{"key":"17_CR20","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang J, Han Y, Xia X, Zeng R, Fan X, Zhang B, Wang K, Lei J (2025) Cryo-EM reveals a double oligomeric ring scaffold of the CHIKV NsP3 peptide in complex with the NTF2L domain of Host G3BP1. mBio 16:e0396724.\u2002https:\/\/doi.org\/10.1128\/MBIO.03967-24","DOI":"10.1128\/MBIO.03967-24"},{"key":"17_CR21","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1128\/JVI.01506-12","volume":"86","author":"JJ Fros","year":"2012","unstructured":"Fros JJ, Domeradzka NE, Baggen J, Geertsema C, Flipse J, Vlak JM, Pijlman GP (2012) Chikungunya virus NsP3 blocks stress granule assembly by recruitment of G3BP into cytoplasmic foci. J Virol 86:10873\u201310879. https:\/\/doi.org\/10.1128\/JVI.01506-12","journal-title":"J Virol"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/J.VIRS.2023.05.007","volume":"38","author":"P Yin","year":"2023","unstructured":"Yin P, Jian X, Liu Y, Liu Y, Lv L, Cui H, Zhang L (2023) Elucidating cellular interactome of chikungunya virus identifies host dependency factors. Virol Sin 38:497\u2013507. https:\/\/doi.org\/10.1016\/J.VIRS.2023.05.007","journal-title":"Virol Sin"},{"key":"17_CR23","doi-asserted-by":"publisher","first-page":"110551","DOI":"10.1016\/J.VIROL.2025.110551","volume":"608","author":"S Mahajan","year":"2025","unstructured":"Mahajan S, Kumar R, Singh A, Dhaka P, Pareek A, Kumar P, Tomar S (2025) Targeting the host protein G3BP1 for the discovery of novel antiviral inhibitors against chikungunya virus. Virology 608:110551. https:\/\/doi.org\/10.1016\/J.VIROL.2025.110551","journal-title":"Virology"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"113965","DOI":"10.1016\/J.CELREP.2024.113965","volume":"43","author":"Z Yang","year":"2024","unstructured":"Yang Z, Johnson BA, Meliopoulos VA, Ju X, Zhang P, Hughes MP, Wu J, Koreski KP, Clary JE, Chang TC et al (2024) Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity. Cell Rep 43:113965. https:\/\/doi.org\/10.1016\/J.CELREP.2024.113965","journal-title":"Cell Rep"},{"key":"17_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60949-1","volume":"16","author":"K Broderick","year":"2025","unstructured":"Broderick K, Moutaoufik MT, Saccon T, Malty R, Amin S, Phanse S, Joseph TP, Zilocchi M, Hosseinnia A, Istace Z et al (2025) Human protein interaction networks of ancestral and variant SARS-CoV-2 in organ-specific cells and bodily fluids. Nat Commun 16: 5784. https:\/\/doi.org\/10.1038\/s41467-025-60949-1","journal-title":"Nat Commun"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"110111","DOI":"10.1016\/j.abb.2024.110111","volume":"759","author":"M Bhutkar","year":"2024","unstructured":"Bhutkar M, Saha A, Tomar S (2024) Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against chikungunya virus. Arch Biochem Biophys 759:110111","journal-title":"Arch Biochem Biophys"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","volume":"154","author":"KM Feibelman","year":"2018","unstructured":"Feibelman KM, Fuller BP, Li L, LaBarbera DV, Geiss BJ (2018) Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme. Antivir Res 154:124\u2013131","journal-title":"Antivir Res"},{"issue":"1","key":"17_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep31819","volume":"6","author":"L Delang","year":"2016","unstructured":"Delang L, Li C, Tas A, Qu\u00e9rat G, Albulescu IC, De Burghgraeve T, Guerrero NS, Gigante A, Piorkowski G, Decroly E, Jochmans D (2016) The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. Sci Rep 6(1):31819","journal-title":"Sci Rep"},{"issue":"3","key":"17_CR29","doi-asserted-by":"publisher","first-page":"e01943","DOI":"10.1128\/aac.01943-21","volume":"66","author":"R Mudgal","year":"2022","unstructured":"Mudgal R, Bharadwaj C, Dubey A, Choudhary S, Nagarajan P, Aggarwal M, Ratra Y, Basak S, Tomar S (2022) Selective estrogen receptor modulators limit alphavirus infection by targeting the viral capping enzyme nsP1. Antimicrob Agents Chemother 66(3):e01943\u201321","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR30","doi-asserted-by":"publisher","first-page":"105446","DOI":"10.1016\/J.ANTIVIRAL.2022.105446","volume":"208","author":"Q Deng","year":"2022","unstructured":"Deng Q, Guo Z, Hu H, Li Q, Zhang Y, Wang J, Liao C, Guo C, Li X, Chen Z et al (2022) Inhibition of chikungunya virus early replication by intracellular nanoantibodies targeting NsP2 epitope rich region. Antiviral Res 208:105446. https:\/\/doi.org\/10.1016\/J.ANTIVIRAL.2022.105446","journal-title":"Antiviral Res"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"109989","DOI":"10.1016\/j.compbiomed.2025.109989","volume":"189","author":"N Kalam","year":"2025","unstructured":"Kalam N, Ali R, Balasubramaniam VR (2025) Exploring the potential of direct-acting antivirals against chikungunya virus through structure-based drug repositioning and molecular dynamic simulations. Comput Biol Med 189:109989","journal-title":"Comput Biol Med"},{"key":"17_CR32","first-page":"100376","volume":"8","author":"M Mastalipour","year":"2025","unstructured":"Mastalipour M, Gering I, Coronado MA, Gonz\u00e1lez JE, Willbold D, Eberle RJ (2025) Novel peptide inhibitor for the chikungunya virus nsP2 protease: identification and characterization. Curr Res Microb Sci 8:100376","journal-title":"Curr Res Microb Sci"},{"issue":"12","key":"17_CR33","doi-asserted-by":"publisher","first-page":"e1012816","DOI":"10.1371\/journal.ppat.1012816","volume":"20","author":"KB Sharma","year":"2024","unstructured":"Sharma KB, Subramani C, Ganesh K, Sharma A, Basu B, Balyan S, Sharma G, Ka S, Deb A, Srivastava M, Chugh S (2024) Withaferin A inhibits chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection. Plos Pathogens 20(12):e1012816","journal-title":"Plos Pathogens"},{"key":"17_CR34","doi-asserted-by":"publisher","unstructured":"Mastalipour M, Coronado MA, Hern\u00e1ndez Gonz\u00e1lez JE, Willbold D, Eberle RJ (2026) Inhibition of Chikungunya virus nsP2 protease in vitro by scorpion venom peptide pantinin-1. PloS One. 21(4):e0346930. https:\/\/doi.org\/10.1371\/journal.pone.0346930","DOI":"10.1371\/journal.pone.0346930"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.biochi.2018.04.004","volume":"149","author":"H Singh","year":"2018","unstructured":"Singh H, Mudgal R, Narwal M, Kaur R, Singh VA, Malik A, Chaudhary M, Tomar S (2018) Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease. Biochimie. 149:51\u201361","journal-title":"Biochimie."},{"issue":"1","key":"17_CR36","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1038\/s41598-022-14790-x","volume":"12","author":"MC Freire","year":"2022","unstructured":"Freire MC, Basso LG, Mendes LF, Mesquita NC, Mottin M, Fernandes RS, Policastro LR, Godoy AS, Santos IA, Ruiz UE, Caruso IP (2022) Characterization of the RNA-dependent RNA polymerase from chikungunya virus and discovery of a novel ligand as a potential drug candidate. Sci Rep.22 12(1):10601","journal-title":"Sci Rep.22"},{"issue":"6","key":"17_CR37","first-page":"e00420","volume":"15","author":"P Yin","year":"2024","unstructured":"Yin P, May NA, Lello LS, Fayed A, Parks MG, Drobish AM, Wang S, Andrews M, Sticher Z, Kolykhalov AA, Natchus MG (2024) 4\u2032-Fluorouridine inhibits alphavirus replication and infection in vitro and in vivo. Mbio.12 15(6):e00420\u201324","journal-title":"Mbio.12"},{"issue":"5","key":"17_CR38","doi-asserted-by":"publisher","first-page":"e0126360","DOI":"10.1371\/journal.pone.0126360","volume":"10","author":"HA Rothan","year":"2015","unstructured":"Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R (2015) A combination of doxycycline and ribavirin alleviated chikungunya infection. PloS one. 13 10(5):e0126360","journal-title":"PloS one. 13"},{"key":"17_CR39","doi-asserted-by":"crossref","unstructured":"Franco EJ, Rodriquez JL, Pomeroy JJ, Hanrahan KC, Brown AN (2018) The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Antivir Chem Chemother 26:2040206618807580","DOI":"10.1177\/2040206618807580"},{"issue":"2","key":"17_CR40","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.01389-18","volume":"63","author":"AC Ferreira","year":"2019","unstructured":"Ferreira AC, Reis PA, de Freitas CS, Sacramento CQ, Villas B\u00f4as Hoelz L, Bastos MM, Mattos M, Rocha N, Gomes de Azevedo Quintanilha I, da Silva Gouveia Pedrosa C, Rocha Quintino Souza L (2019) Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication. Antimicrob Agents Chemother 63(2):10\u2013128.","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR41","doi-asserted-by":"crossref","unstructured":"Fatma B, Kumar R, Singh VA, Nehul S, Sharma R, Kesari P, Kuhn RJ, Tomar S (2020) Alphavirus capsid protease inhibitors as potential antiviral agents for chikungunya infection. Antivir Res 179:104808","DOI":"10.1016\/j.antiviral.2020.104808"},{"issue":"7","key":"17_CR42","doi-asserted-by":"publisher","first-page":"e0133511","DOI":"10.1371\/journal.pone.0133511","volume":"10","author":"YJ Ho","year":"2015","unstructured":"Ho YJ, Wang YM, Lu JW, Wu TY, Lin LI, Kuo SC, Lin CC (2015) Suramin inhibits chikungunya virus entry and transmission. PLoS One 10(7):e0133511","journal-title":"PLoS One"},{"issue":"44","key":"17_CR43","doi-asserted-by":"publisher","first-page":"27637","DOI":"10.1073\/pnas.2008051117","volume":"117","author":"QF Zhou","year":"2020","unstructured":"Zhou QF, Fox JM, Earnest JT, Ng TS, Kim AS, Fibriansah G, Kostyuchenko VA, Shi J, Shu B, Diamond MS, Lok SM (2020) Structural basis of chikungunya virus inhibition by monoclonal antibodies. Proc Natl Acad Sci. 3 117(44):27637\u201327645","journal-title":"Proc Natl Acad Sci. 3"},{"issue":"11","key":"17_CR44","doi-asserted-by":"publisher","first-page":"e1008061","DOI":"10.1371\/journal.ppat.1008061","volume":"15","author":"JA Quiroz","year":"2019","unstructured":"Quiroz JA, Malonis RJ, Thackray LB, Cohen CA, Pallesen J, Jangra RK, Brown RS, Hofmann D, Holtsberg FW, Shulenin S, Nyakatura EK (2019) Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins. PLoS Pathog. 7 15(11):e1008061","journal-title":"PLoS Pathog. 7"},{"issue":"19","key":"17_CR45","first-page":"10","volume":"94","author":"U Tumkosit","year":"2020","unstructured":"Tumkosit U, Siripanyaphinyo U, Takeda N, Tsuji M, Maeda Y, Ruchusatsawat K, Shioda T, Mizushima H, Chetanachan P, Wongjaroen P, Matsuura Y (2020) Anti-chikungunya virus monoclonal antibody that inhibits viral fusion and release. J Virol.15 94(19):10\u2013128","journal-title":"J Virol.15"},{"key":"17_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64687-2","volume":"16","author":"X Han","year":"2025","unstructured":"Han X, Ji C, Tian S, Wang F, Cao GP, Li D, Duan X, Tong Z, Qi J, Wang Q et al (2025) Neutralizing antibodies against chikungunya virus and structural elucidation of their mechanism of action. Nat Commun 16:9682. https:\/\/doi.org\/10.1038\/s41467-025-64687-2","journal-title":"Nat Commun"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"e1003312","DOI":"10.1371\/JOURNAL.PPAT.1003312","volume":"9","author":"P Pal","year":"2013","unstructured":"Pal P, Dowd KA, Brien JD, Edeling MA, Gorlatov S, Johnson S, Lee I, Akahata W, Nabel GJ, Richter MKS et al (2013) Development of a highly protective combination monoclonal antibody therapy against chikungunya virus. PLoS Pathog 9:e1003312. https:\/\/doi.org\/10.1371\/JOURNAL.PPAT.1003312","journal-title":"PLoS Pathog"},{"key":"17_CR48","doi-asserted-by":"publisher","unstructured":"Goto K, Amano R, Ichinose A, Michishita A, Hamada M, Nakamura Y, Takahashi M (2025) Generation of RNA aptamers against chikungunya virus E2 envelope protein. J Virol 99:e0209524.\u2002https:\/\/doi.org\/10.1128\/JVI.02095-24","DOI":"10.1128\/JVI.02095-24"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/J.SBSR.2018.100248","volume":"22","author":"MB Coppock","year":"2019","unstructured":"Coppock MB, Hurley M, Jones C, Erickson D, Stratis-Cullum DN (2019) A novel discovery, maturation, and assay integration approach for the development of ruggedized multi-valent capture receptors exemplified against the chikungunya virus E2 protein. Sens Bios Res 22:100248. https:\/\/doi.org\/10.1016\/J.SBSR.2018.100248","journal-title":"Sens Bios Res"},{"key":"17_CR50","doi-asserted-by":"publisher","unstructured":"Song L, Fu G, Li J, Chen Z, Fu L, Yu C, Qiang L, Li J, Fang T, Yuan H et al (2025) Highly potent neutralizing nanobodies acting against chikungunya virus infection via inhibiting multiple stages of the viral life cycle. Int J Mol Sci 26:3982. https:\/\/doi.org\/10.3390\/IJMS26093982","DOI":"10.3390\/IJMS26093982"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12688\/f1000research.13242.1","volume":"7","author":"A Sharma","year":"2018","unstructured":"Sharma A, Bhomia M, Yeh TJ, Singh J, Maheshwari RK (2018) Miltefosine inhibits chikungunya virus replication in human primary dermal fibroblasts. F1000Research 7:9","journal-title":"F1000Research"},{"issue":"7","key":"17_CR52","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.00135-21","volume":"65","author":"S Nam","year":"2021","unstructured":"Nam S, Ga YJ, Lee JY, Hwang WY, Jung E, Shin JS, Chen W, Choi G, Zhou B, Yeh JY, Go YY (2021) Radicicol inhibits chikungunya virus replication by targeting nonstructural protein 2. Antimicrob Agents Chemother 65(7):10\u2013128","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nature09555","volume":"468","author":"JE Voss","year":"2010","unstructured":"Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA (2010) Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography. Nature 468:709\u2013712.\u2002https:\/\/doi.org\/10.1038\/nature09555","journal-title":"Nature"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nature02239","volume":"427","author":"DL Gibbons","year":"2004","unstructured":"Gibbons DL, Vaney MC, Roussel A, Vigouroux A, Reilly B, Lepault J, Kielian M, Rey FA (2004) Conformational change and protein\u2013protein interactions of the fusion protein of Semliki Forest virus. Nature 427:320\u2013325. https:\/\/doi.org\/10.1038\/nature02239","journal-title":"Nature"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"e02015","DOI":"10.1128\/JVI.02015-24","volume":"99","author":"Z-Q Li","year":"2024","unstructured":"Li Z-Q, Zhao L-X, Wang S-Y, Hu C-Y, Wang Y-Y, Yang Y (2024) YBX1 is required for assembly of viral replication complexes of chikungunya virus and replication of multiple alphaviruses. J Virol 99:e02015\u201324. https:\/\/doi.org\/10.1128\/JVI.02015-24","journal-title":"J Virol"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/MBIO.02623-20","volume":"11","author":"F Taschuk","year":"2020","unstructured":"Taschuk F, Tapescu I, Moy RH, Cherry S (2020) Ddx56 binds to chikungunya virus RNA to control infection. mBio 11:1\u201316. https:\/\/doi.org\/10.1128\/MBIO.02623-20","journal-title":"mBio"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1016\/J.MOLCEL.2023.10.032","volume":"83","author":"MG Thompson","year":"2023","unstructured":"Thompson MG, Horner SM (2023) The evil DExH\/D: chikungunya virus runs but cannot hide from DDX39A. Mol Cell 83:3948\u20133949. https:\/\/doi.org\/10.1016\/J.MOLCEL.2023.10.032","journal-title":"Mol Cell"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/J.VIROL.2020.05.010","volume":"548","author":"PK Tripathi","year":"2020","unstructured":"Tripathi PK, Soni A, Singh Yadav SP, Kumar A, Gaurav N, Raghavendhar S, Sharma P, Sunil S, Ashish, Jayaram B et al (2020) Evaluation of novobiocin and telmisartan for anti-CHIKV activity. Virology 548:250\u2013260. https:\/\/doi.org\/10.1016\/J.VIROL.2020.05.010","journal-title":"Virology"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/J.IJBIOMAC.2020.05.165","volume":"160","author":"PK Tripathi","year":"2020","unstructured":"Tripathi PK, Singh J, Gaurav N, Garg DK, Patel AK (2020) In-silico and biophysical investigation of biomolecular interaction between naringin and NsP2 of the chikungunya virus. Int J Biol Macromol 160:1061\u20131066. https:\/\/doi.org\/10.1016\/J.IJBIOMAC.2020.05.165","journal-title":"Int J Biol Macromol"},{"key":"17_CR60","doi-asserted-by":"publisher","unstructured":"Rani R, Nehul S, Choudhary S, Upadhyay A, Sharma GK, Kumar P, Tomar S (2023) Revealing and evaluation of antivirals targeting multiple druggable sites of RdRp complex in SARS-CoV-2. bioRxiv, 2023.07.24.550324. https:\/\/doi.org\/10.1101\/2023.07.24.550324","DOI":"10.1101\/2023.07.24.550324"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41392-021-00763-5","volume":"6","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang J, Duan Z, Wang N, Sun X, Zhang Y, Fu L, Liu K, Yang Y, Pan S et al (2021) High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease. Signal Transduct Target Ther 6:356. https:\/\/doi.org\/10.1038\/s41392-021-00763-5","journal-title":"Signal Transduct Target Ther"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1021\/ACS.BIOCHEM.4C00535","volume":"64","author":"A Singh","year":"2025","unstructured":"Singh A, Jangid K, Nehul S, Dhaka P, Rani R, Pareek A, Sharma GK, Kumar P, Tomar S (2025) Structural and mechanistic insights into the main protease (Mpro) dimer interface destabilization inhibitor: unveiling new therapeutic avenues against SARS-CoV-2. Biochemistry 64:1589\u20131605.\u2002https:\/\/doi.org\/10.1021\/ACS.BIOCHEM.4C00535","journal-title":"Biochemistry"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/J.VIROL.2017.12.020","volume":"515","author":"R Sharma","year":"2018","unstructured":"Sharma R, Kesari P, Kumar P, Tomar S (2018) Structure-function insights into chikungunya virus capsid protein: small molecules targeting capsid hydrophobic pocket. Virology 515:223\u2013234.\u2002https:\/\/doi.org\/10.1016\/J.VIROL.2017.12.020","journal-title":"Virology"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"e15651","DOI":"10.1016\/j.heliyon.2023.e15651","volume":"9","author":"AM Khalenkov","year":"2023","unstructured":"Khalenkov AM, Norton MG, Scott DE (2023) Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR. Heliyon 9:e15651. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15651","journal-title":"Heliyon"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1128\/JVI.01408-16","volume":"90","author":"S Khurana","year":"2016","unstructured":"Khurana S, Chung KY, Coyle EM, Meijer A, Golding H (2016) Antigenic fingerprinting of antibody response in humans following exposure to highly pathogenic H7N7 avian influenza virus: evidence for anti-PA-X antibodies. J Virol 90:9383\u20139393.\u2002https:\/\/doi.org\/10.1128\/JVI.01408-16","journal-title":"J Virol"},{"key":"17_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11296-5","volume":"10","author":"S Khurana","year":"2019","unstructured":"Khurana S, Hahn M, Coyle EM, King LR, Lin TL, Treanor J, Sant A, Golding H (2019) Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans. Nat Commun 10:3338. https:\/\/doi.org\/10.1038\/s41467-019-11296-5","journal-title":"Nat Commun"},{"key":"17_CR67","doi-asserted-by":"publisher","unstructured":"Scott Smith AA, Silva LA, Fox JM, Diamond MS, Dermody TS, Crowe JE, Smith SA, Flyak AI, Kose N et al (2015) Isolation and characterization of broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus. Cell Host Microbe 18(1):86-95.\u2002https:\/\/doi.org\/10.1016\/j.chom.2015.06.009","DOI":"10.1016\/j.chom.2015.06.009"},{"key":"17_CR68","doi-asserted-by":"publisher","unstructured":"Song H, Zhao Z, Chai Y, Qi J, Gao F, Gao G F (2019) Molecular basis of arthritogenic alphavirus receptor MXRA8 binding to chikungunya virus envelope. Cell 177:1714\u20131724.e12. https:\/\/doi.org\/10.1016\/j.cell.2019.04.008","DOI":"10.1016\/j.cell.2019.04.008"},{"key":"17_CR69","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/J.CELL.2019.04.006","volume":"177","author":"K Basore","year":"2019","unstructured":"Basore K, Kim AS, Nelson CA, Zhang R, Smith BK, Uranga C, Vang L, Cheng M, Gross ML, Smith J et al (2019) Cryo-EM structure of chikungunya virus in complex with the Mxra8 receptor. Cell 177:1725. https:\/\/doi.org\/10.1016\/J.CELL.2019.04.006","journal-title":"Cell"},{"key":"17_CR70","doi-asserted-by":"publisher","unstructured":"Singh V, Nehul S, Kumar CS, Banerjee M, Kumar P, Sharma G, Tomar S (2023) Chimeric chikungunya virus-like particles with surface exposed SARS-CoV-2 RBD elicits potent immunogenic responses in mice. bioRxiv, 2023.01.29.526074. https:\/\/doi.org\/10.1101\/2023.01.29.526074","DOI":"10.1101\/2023.01.29.526074"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/J.BIOS.2016.08.099","volume":"93","author":"H Ashiba","year":"2017","unstructured":"Ashiba H, Sugiyama Y, Wang X, Shirato H, Higo-Moriguchi K, Taniguchi K, Ohki Y, Fujimaki M (2017) Detection of norovirus virus-like particles using a surface plasmon resonance-assisted fluoroimmunosensor optimized for quantum dot fluorescent labels. Biosens Bioelectron 93:260\u2013266. https:\/\/doi.org\/10.1016\/J.BIOS.2016.08.099","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"17_CR72","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1109\/TNB.2023.3286269","volume":"23","author":"RB Rumi","year":"2023","unstructured":"Rumi RB, Paul AK, Alyami SA, Moni MA (2023) Multi-disease detection using a prism-based surface plasmon resonance sensor: a TMM and FEM approach. IEEE Trans NanoBiosci 23(1):51\u201362","journal-title":"IEEE Trans NanoBiosci"},{"key":"17_CR73","unstructured":"Cytiva: Biacore T200 Software Handbook (Version 3.2.1). Cytiva (2024)"},{"key":"17_CR74","unstructured":"GE Healthcare: Biacore T200 Getting Started (Edition AB 28-9840-98). GE Healthcare (2013)"}],"container-title":["Methods in Molecular Biology","Chikungunya Virus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5496-5_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T06:08:47Z","timestamp":1789366127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5496-5_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"ISBN":["9781071654958","9781071654965"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5496-5_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"15 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Ethics"}}]}}